
via USC
Scientists develop a new non-opioid pain killer with fewer side effects
- Promising compound benzyloxy-cyclopentyladenosine (BnOCPA) found to be a potent and selective pain killer in test model systems
- BnOCPA is also selective in its action, and non-addictive, opening up the potential for the development of potent analgesics without side effects
- Results revealed in paper published by scientists at the University of Warwick, University of Cambridge, University of Bern, Monash University, Coventry University and industrial partners
A promising new non-opioid painkiller (analgesic) with potentially fewer side effects compared to other potent painkillers, has been discovered.
A team of scientists, co-led by researchers from the School of Life Sciences, University of Warwick, has investigated a compound called BnOCPA (benzyloxy-cyclopentyladenosine), found to be a potent and selective analgesic which is non-addictive in test model systems. BnOCPA also has a unique mode of action and potentially opens a new pipeline for the development of new analgesic drugs.
The research by the team at Warwick, together with colleagues at the University of Cambridge, University of Bern, Monash University, Coventry University and industrial collaborators, is published in Nature Communications in a paper entitled “Selective activation of G?ob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression”.
In the UK between one third and one half of the population report moderately to severely disabling chronic pain. Such pain has a negative impact on quality of life and many of the commonly used pain killers produce side effects. Opioid drugs, such as morphine and oxycodone, can lead to addiction and are dangerous in overdose. There is therefore an unmet need for new and potent pain killing drugs.
Many drugs act via proteins on the surface of cell surfaces that activate adapter molecules called G proteins. The activation of G proteins can lead to many cellular effects. BnOCPA is unique in that it only activates one type of G protein, leading to very selective effects and thus reducing potential side effects.
Dr Mark Wall, from the School of Life Sciences at the University of Warwick, who led the research said: “The selectivity and potency of BnOCPA make it truly unique and we hope that with further research it will be possible to generate potent painkillers to help patients cope with chronic pain.”
Professor Bruno Frenguelli, principal investigator on the project, from the University of Warwick’s School of Life Sciences, said: “This is a fantastic example of serendipity in science. We had no expectations that BnOCPA would behave any differently from other molecules in its class, but the more we looked into BnOCPA we discovered properties that had never been seen before, and which may open up new areas of medicinal chemistry.”
Professor Graham Ladds, co-principal investigator on the project, from the University of Cambridge, said: “This is an amazing story looking at agonist bias for a GPCR. Not only does BnOCPA have the potential to be a new type of painkiller, but it has shown us a new method for targeting other GPCRs in drug discovery.”
Original Article: Scientists develop a new non-opioid pain killer with fewer side effects
More from: University of Warwick | University of Cambridge | University of Bern | Monash University | Coventry University
The Latest on: New non-opioid pain killer
- With overdoses skyrocketing, Congress must consider non-opioid alternatives to pain managementon August 5, 2022 at 2:10 pm
Complementary and integrative healthcare providers, including chiropractic physicians, acupuncturists, and massage therapists, provide effective and safe treatments for pain. Yet, they are too often ...
- Personalized text messaging program to prevent opioid misuse launches in SCon August 3, 2022 at 6:14 am
COLUMBIA, SC (WSPA) — State officials and a national nonprofit have teamed up to launch a new personalized text ... people on the wide array of non-opioid pain relievers available and offers ...
- Scientists Create New Non-Opioid Painkiller With Fewer Side Effectson July 21, 2022 at 1:39 am
Researchers have developed a promising new non-opioid painkiller, potentially with fewer side effects compared to other potent painkillers, and a unique mode of action, potentially opening a new ...
- Scientists develop a new non-opioid pain killer with fewer side effectson July 20, 2022 at 7:11 am
A promising new non-opioid ... disabling chronic pain. Such pain has a negative impact on quality of life and many of the commonly used pain killers produce side effects. Opioid drugs, such ...
- Scientists develop a new non-opioid pain killer with fewer side effectson July 20, 2022 at 6:22 am
Promising compound benzyloxy-cyclopentyladenosine (BnOCPA) found to be a potent and selective pain killer in test ... industrial partners A promising new non-opioid painkiller (analgesic) with ...
- Scientists develop a new non-opioid pain killer with fewer side effectson July 19, 2022 at 5:00 pm
Scientists develop a new non-opioid pain killer with fewer side effects Date: July 20, 2022 Source: University of Warwick Summary: Scientists have investigated a compound called BnOCPA (benzyloxy ...
- New opioid legislation not likely to helpon July 17, 2022 at 11:16 am
The recent passing and signing of Florida’s new opioid legislation ... any amounts of these pain killers for their chronically ill patients. Ingesting opioids on a continuing basis is more ...
- The Problems With Opioid Addiction - And Response (5)on July 16, 2022 at 5:00 pm
Prescribing an opioid medication ... and away from pain management clinics. This entire topic is disgusting and misguided, causing "Opioidhobia" by misinformed, judgmental and non scientifically ...
- Understanding Long-term Opioid Prescribing for Non-cancer Pain in Primary Care: A Qualitative Studyon July 5, 2022 at 5:00 pm
'[Male, 61 yrs, maintained on weak opioids, D1; 64&208] Patients repeatedly consulted with poorly controlled pain despite continuing or even increased doses and strengths of pain killers ...
- Pain Managementon September 27, 2021 at 2:24 pm
Taking pain killers is ... is short for the non-steroidal anti-inflammatory drug. These not only relieve pain, but also reduce inflammation. An example is ibuprofen. Opioids: These are reserved ...
via Bing News
The Latest on: New non-opioid pain killer
via Google News
Add Comment